尿毒症患者的甲状腺癌
Thyroid cancer in uremic patients.
作者信息
Hatada T, Okada K, Ishii H, Ichii S, Utsunomiya J
机构信息
Second Department of Surgery, Hyogo College of Medicine, Japan.
出版信息
Tumori. 1998 Jul-Aug;84(4):504-5. doi: 10.1177/030089169808400413.
BACKGROUND
The combination of thyroid cancer and secondary uremic hyperparathyroidism has thus far been reported in only 25 cases.
METHODS
Here we report our experience of 19 patients with secondary hyperparathyroidism who underwent parathyroidectomy.
RESULTS
Thyroid nodules were present in five patients (26.3%), including one with a benign nodule and four with papillary thyroid cancer (21.1%).
CONCLUSION
Our experience suggests that, in order to make a correct diagnosis, clinicians should consider the possibility of thyroid cancer in uremic patients with secondary hyperparathyroidism.
背景
甲状腺癌与继发性尿毒症性甲状旁腺功能亢进并存的情况，迄今为止仅报道过25例。
方法
本文报告了我们对19例接受甲状旁腺切除术的继发性甲状旁腺功能亢进患者的治疗经验。
结果
5例患者（26.3%）存在甲状腺结节，其中1例为良性结节，4例为甲状腺乳头状癌（21.1%）。
结论
我们的经验表明，为了做出正确诊断，临床医生应考虑继发性甲状旁腺功能亢进的尿毒症患者发生甲状腺癌的可能性。
Zotero 插件